Latest filing published 03 Apr 2008 for ENCYSIVE PHARMACEUTICALS INC, €409k.
No signal scores available.
George W. Cole is a declared insider of Encysive Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 2 March 2006 to 1 April 2008, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 April 2008, the filings show a transaction worth €409k in Encysive Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations